Authors:
KOTZMANN H
RIEDL M
BERNECKER P
CLODI M
KAINBERGER F
KAIDER A
WOLOSZCZUK W
LUGER A
Citation: H. Kotzmann et al., EFFECT OF LONG-TERM GROWTH-HORMONE SUBSTITUTION THERAPY ON BONE-MINERAL DENSITY AND PARAMETERS OF BONE METABOLISM IN ADULT PATIENTS WITH GROWTH-HORMONE DEFICIENCY, Calcified tissue international, 62(1), 1998, pp. 40-46
Citation: Ea. Afify et al., ROLE OF CARBOXYL-TERMINUS OF MU-OPIOID AND DELTA-OPIOID RECEPTOR IN AGONIST-INDUCED DOWN-REGULATION, Molecular brain research, 54(1), 1998, pp. 24-34
Authors:
KOTZMANN H
KOLLER M
ABELA C
CLODI M
RIEDL M
GRANINGER W
NIEDERLE B
LUGER A
Citation: H. Kotzmann et al., EFFECTS OF PARATHYROID-HORMONE AND SERUM-CALCIUM ON THE PHENOTYPE ANDFUNCTION OF MONONUCLEAR-CELLS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM, European journal of clinical investigation, 28(5), 1998, pp. 353-358
Authors:
PORRECA F
TANG QB
BIAN D
RIEDL M
ELDE R
LAI J
Citation: F. Porreca et al., SPINAL OPIOID MU-RECEPTOR EXPRESSION IN LUMBAR SPINAL-CORD OF RATS FOLLOWING NERVE INJURY, Brain research, 795(1-2), 1998, pp. 197-203
Authors:
CLODI M
KOTZMANN H
RIEDL M
SCHMIDT A
BARNAS U
MUHLBACHER F
MUSTAFA G
HORL WH
WALDHAUSL W
MAYER G
LUGER A
Citation: M. Clodi et al., THE LONG-ACTING DOPAMINE AGONIST BROMOCRIPTINE MESYLATE AS ADDITIVE IMMUNOSUPPRESSIVE DRUG AFTER KIDNEY-TRANSPLANTATION, Nephrology, dialysis, transplantation, 12(4), 1997, pp. 748-752
Authors:
SMYTH A
RIEDL M
KIMURA R
OLICK R
SIEGLER M
Citation: A. Smyth et al., END OF LIFE DECISIONS IN AMYOTROPHIC-LATERAL-SCLEROSIS - A CROSS-CULTURAL-PERSPECTIVE, Journal of the neurological sciences, 152, 1997, pp. 93-96
Citation: U. Arvidsson et al., VESICULAR ACETYLCHOLINE TRANSPORTER (VACHT) PROTEIN - A NOVEL AND UNIQUE MARKER FOR CHOLINERGIC NEURONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS, Journal of comparative neurology, 378(4), 1997, pp. 454-467
Authors:
KOTZMANN H
ABELA C
HEINDL J
CLODI M
RIEDL M
BARNAS U
HEINZL H
NIEDERLE B
GEISSLER K
WALDHAUSL W
LUGER A
Citation: H. Kotzmann et al., EFFECT OF SUCCESSFUL PARATHYROIDECTOMY ON HEMATOPOIETIC PROGENITOR CELLS AND PARAMETERS OF RED-BLOOD-CELLS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM, Hormone and Metabolic Research, 29(8), 1997, pp. 387-392
Authors:
KOLLER M
KOTZMANN H
CLODI M
RIEDL M
LUGER A
Citation: M. Koller et al., EFFECT OF ELEVATED SERUM PROLACTIN CONCENTRATIONS ON THE IMMUNOPHENOTYPE OF HUMAN-LYMPHOCYTES, MITOGEN-INDUCED PROLIFERATION AND PHAGOCYTIC-ACTIVITY OF POLYMORPHONUCLEAR CELLS, European journal of clinical investigation, 27(8), 1997, pp. 662-666
Authors:
RIEDL M
SHUSTER S
VULCHANOVA L
WANG JL
LOH HH
ELDE R
Citation: M. Riedl et al., ORPHANIN FQ NOCICEPTIN-IMMURAOREACTIVE NERVE-FIBERS PARALLEL THOSE CONTAINING ENDOGENOUS OPIOIDS IN RAT SPINAL-CORD/, NeuroReport, 7(8), 1996, pp. 1369-1372
Authors:
LAI J
RIEDL M
STONE LS
ARVIDSSON U
BILSKY EJ
WILCOX GL
ELDE R
PORRECA F
Citation: J. Lai et al., IMMUNOFLUORESCENCE ANALYSIS OF ANTISENSE OLIGODEOXYNUCLEOTIDE-MEDIATED KNOCK-DOWN OF THE MOUSE DELTA-OPIOID RECEPTOR IN-VITRO AND IN-VIVO, Neuroscience letters, 213(3), 1996, pp. 205-208
Authors:
TEMPL E
KOELLER M
RIEDL M
WAGNER O
GRANINGER W
LUGER A
Citation: E. Templ et al., ANTERIOR-PITUITARY FUNCTION IN PATIENTS WITH NEWLY-DIAGNOSED RHEUMATOID-ARTHRITIS, British journal of rheumatology, 35(4), 1996, pp. 350-356
Authors:
PIRKER W
RIEDL M
LUGER A
CZECH T
ROSSLER K
ASENBAUM S
ANGELBERGER P
KORNHUBER J
DEECKE L
PODREKA I
BRUCKE T
Citation: W. Pirker et al., DOPAMINE D2 RECEPTOR IMAGING IN PITUITARY-ADENOMAS USING IODINE-123-EPIDEPRIDE AND SPECT, The Journal of nuclear medicine, 37(12), 1996, pp. 1931-1937
Authors:
VULCHANOVA L
ARVIDSSON U
RIEDL M
WANG J
BUELL G
SURPRENANT A
NORTH RA
ELDE R
Citation: L. Vulchanova et al., DIFFERENTIAL DISTRIBUTION OF 2 ATP-GATED ION CHANNELS (P-2X RECEPTORS) DETERMINED BY IMMUNOCYTOCHEMISTRY, Proceedings of the National Academy of Sciences of the United Statesof America, 93(15), 1996, pp. 8063-8067
Authors:
KOTZMANN H
RIEDL M
CLODI M
BARNAS U
KAIDER A
HOCKER P
LUGER A
Citation: H. Kotzmann et al., THE INFLUENCE OF GROWTH-HORMONE SUBSTITUTION THERAPY ON ERYTHROID ANDMYELOID PROGENITOR CELLS AND ON PERIPHERAL-BLOOD CELLS IN ADULT PATIENTS WITH GROWTH-HORMONE DEFICIENCY, European journal of clinical investigation, 26(12), 1996, pp. 1175-1181
Authors:
RIEDL M
KOTZMANN H
CLODI M
PACINI G
WAGNER O
RABENSTEINER D
PRAGER R
LUGER A
Citation: M. Riedl et al., EFFECT OF GROWTH-HORMONE REPLACEMENT THERAPY ON GLUCOSE-METABOLISM INGROWTH-HORMONE DEFICIENT ADULTS, Diabetologia, 39, 1996, pp. 696-696
Authors:
ARVIDSSON U
RIEDL M
KO J
NAKANO AH
VULCHANOVA L
DADO RJ
STONE LS
LAI J
BILKSY EJ
PORRECA F
WILCOX GL
LOH HH
LAW PY
WESSENDORF MW
ELDE R
Citation: U. Arvidsson et al., DIFFERENCES IN THE AVAILABILITY OF ECTODOMAIN AND ENDODOMAIN EPITOPESOF DOR1 IN BRAIN VERSUS CELL-LINES, Molecular biology of the cell, 6, 1995, pp. 1034-1034
Authors:
RIEDL M
HAAS M
OBERBAUER R
GISINGER J
LUGER A
MAYER G
Citation: M. Riedl et al., THE EFFECTS OF PROLONGED SUBSTITUTION OF RECOMBINANT HUMAN GROWTH-HORMONE ON RENAL FUNCTIONAL RESERVE IN GROWTH HORMONE-DEFICIENT ADULTS, Journal of the American Society of Nephrology, 6(5), 1995, pp. 1434-1438
Authors:
ARVIDSSON U
RIEDL M
CHAKRABARTI S
LEE JH
NAKANO AH
DADO RJ
LOH HH
LAW PY
WESSENDORF MW
ELDE R
Citation: U. Arvidsson et al., DISTRIBUTION AND TARGETING OF A MU-OPIOID RECEPTOR (MOR1) IN BRAIN AND SPINAL-CORD, The Journal of neuroscience, 15(5), 1995, pp. 3328-3341